Friday, September 13, 2019

   
 

Educational Sessions

Faculty

Room 202 Management of Renal Impaired MM Patient L Rosinol/J Laubach
Room 203 Management of Extramedullary and CNS Disease
A  Jurczyszyn/S Usmani
Room 204 Management of Elderly Patients with MM A Larocca/S Zweegman
Room 205 Management of POEMS and Castleman's Disease A Dispenzieri/DC Fajgenbaum
Room 210 Management of Challenging Cases Moderator: S Kumar
Panel: R Hajek / N Raje / M Mohty /
S Kastritis 
Room 308 Management of Primary Plasma Cell Leukemia F Gay/M Leiba
Room 309 Management of LC Amyloidosis G Palladini/R Comenzo
Room 310 Management of High Risk MM A Jakubowiak/K Weisel
Room 311 Management of the Refractory MM Patient M Boccadoro/R Orlowski
Room 312 Maintenance Therapy in MM: For whom, and for how long? X Leleu/TBD
Room 313 Management of Waldenstrom's Macroglobulinemia R Garcia Sanz/J Castillo
   

Plenary Session

Faculty

Janssen Supported Plenary Session

 
Session Chairs P Moreau/S Usmani
Antibody Treatment Approaches in MM A Chari
CD38 targeted treatment of MM M Dimopoulos
CS1 targeted treatment of MM S Lonial
BiTEs and Bi-Specific Antibodies for MM H Ensele
Antibody Conjugates for MM S Trudel
   
Treatment of Newly Diagnosed Myeloma Transplant Eligible  
Session Chairs M Mohty/A Krishnan
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   
Treatment of Newly Diagnosed Myeloma Transplant Eligible B Durie/S Jagannath
Session Chairs  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   

Expositions and Lunch

   
Antibody Based Approaches to MM  
Session Chairs R Niesvizky/R Hajek
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts   
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   
Immunotherapeutic Approaches to MM  
Session Chairs D Avigan/T Martin
Selected from Submitted Abstracts  
Selected from Submitted Abstracts   
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
Selected from Submitted Abstracts  
   
Hot Topics in Myeloma  
Can better metrics accelerate drug approval in MM?  
 Session Moderators KC Anderson/JL Harrouseau
 The US Perspective R Pazdur
 The European Perspective H Enzmann
   
Is CAR T cell therapy meeting expectations in MM?  
Session Moderators I Borello/D Joshua
Panelists - A Cohen / J Berdeja / N Munshi / N Shah  
   
Keynote Addresses  
Does Single Cell Dissection offer new insights into
MM Pathogenesis and Therapy?
I Amit
Is MM a heterogeneous disease that requires a diverse
approach for discovery and treatment?
KC Anderson
   

Poster Session and Reception at Hynes Convention Center

 

Workshop Organizers

Christopher Patterson
IMW 17 Secretariat

Dana Farber Cancer Institute
Mayor 548
450 Brookline Avenue
Boston, MA 02215
+1 617 632 6285

cpatterson1@partners.org

Join the IMS Today

Enjoy the

benefits of Membership

in the

International Myeloma Society

Become a Member Today

Housing & Registration

Accommodations


c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
+ 1 703-449-6418 (International)

Reserve Now

Contact the IMS

International Myeloma Society

Lisa Sikkink, IMS Assistant

International Myeloma Society
Mayo Clinic
Siebens 6-60
200 First Street SW
Rochester, MN 55905
+1 507 284 3725

adminassistant@myelomasociety.org